Antibiotics Market Size, Share, Growth Analysis, By Drug Class(Cephalosporin, Penicillin, Fluoroquinolone, Macrolides), By Action Mechanism(Cell Wall Synthesis Inhibitors, Protein Synthesis Inhibitors, DNA Synthesis Inhibitors, RNA Synthesis Inhibitors), By Type(Branded Antibiotics, Generic Antibiotics), By Region - Industry Forecast 2024-2031

Asia Pacific dominated the market and accounted for 43.8% of the revenue in the region owing to rise in infectious diseases, rise in dispensing of non-prescription drugs, presence of well-established hospitals & clinics. According to a University of Oslo article published in May 2023, the main suppliers of antibiotics are India and China. Antibiotics and antimicrobial products from both countries are of great importance to the world. China is the world’s leading producer and manufacturer of antibiotics. Similarly, according to a BBC news article published in September 2023, national data shows that out of 29.1% of the 125 million people aged 65 or over, Japan has the lowest fertility rate in the world. Older people are more susceptible to infectious diseases. In addition, the incidence of drug-resistant infectious diseases is increasing, increasing the demand for alternative treatment options. 

North America is anticipated to witness giant growth. These markets are notably standardized with improvements in healthcare infrastructure. Regional market growth is driven with the aid of rising incidences of infectious sicknesses, which, in turn, are boosting the demand for new antimicrobial formulations. The growth is also driven by elevated research and development, in addition to through quite a few existing antibiotic stewardship projects. According to a Definitive Healthcare article published in August 2023, the wide variety of antibiotic prescriptions issued by healthcare carriers.